SCHEMBL1747663

SCHEMBL1747663

Cc1oncc1[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9782028 0.67
SCHEMBL7045502 0.67
SCHEMBL10279027 0.63
SCHEMBL13836590 0.62
SCHEMBL2517257 0.62
SCHEMBL12777837 0.62
SCHEMBL12956727 0.60 BRD4 (0.33)
Hydrochloric Acid SCHEMBL752660 0.60
SCHEMBL745819 0.59 BRD4 (0.32)
SCHEMBL1023500 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3310755-B1 A NOVEL PROCESS FOR THE PREPARATION OF TERIFLUNOMIDE BIOCON LTD (IN) 2021-02-24 EP claimed
EP-1817036-B1 MODULATORS OF MUSCARINIC RECEPTORS VERTEX PHARMA (US) 2012-07-04 EP claimed
EP-1817036-A2 MODULATORS OF MUSCARINIC RECEPTORS Vertex Pharmaceuticals Incorporated (US) 2007-08-15 EP claimed
US-20060270653-A1 Modulators of muscarinic receptors VERTEX PHARMACEUTICALS INCORPORATED 2006-11-30 US claimed
WO-2006058303-A2 MODULATORS OF MUSCARINIC RECEPTORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2006-06-01 WO claimed
US-6660858-B2 Made by reacting a benzoxazole with a leaving group at the 2 position and a diamine of given formula LION BIOSCIENCE AG (DE) 2003-12-09 US claimed
US-20020161028-A1 2-aminobenzoxazole derivatives and combinatorial libraries thereof LION BIOSCIENCE, AG (DE) 2002-10-31 US claimed
WO-2002079753-A2 2-AMINOBENZOXAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF LION BIOSCIENCE AG (DE) 2002-10-10 WO claimed
EP-3310755-B1 A NOVEL PROCESS FOR THE PREPARATION OF TERIFLUNOMIDE BIOCON LTD (IN) 2021-02-24 EP disclosed
EP-3310755-A1 A NOVEL PROCESS FOR THE PREPARATION OF TERIFLUNOMIDE Biocon Limited (IN) 2018-04-25 EP disclosed
EP-3310755-A1 A NOVEL PROCESS FOR THE PREPARATION OF TERIFLUNOMIDE Biocon Limited (IN) 2018-04-25 EP disclosed
WO-2016203410-A1 A NOVEL PROCESS FOR THE PREPARATION OF TERIFLUNOMIDE BIOCON LIMITED (IN) 2016-12-22 WO disclosed
WO-2016203410-A1 A NOVEL PROCESS FOR THE PREPARATION OF TERIFLUNOMIDE BIOCON LIMITED (IN) 2016-12-22 WO disclosed
EP-2785708-B1 INSECTICIDAL TRIAZINONE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2016-03-23 EP disclosed
EP-1310488-A1 FUSED BICYCLIC AMIDE COMPOUNDS AND MEDICINAL USE THEREOF Mitsubishi Pharma Corporation (JP) 2003-05-14 EP disclosed
US-20020161028-A1 2-aminobenzoxazole derivatives and combinatorial libraries thereof LION BIOSCIENCE, AG (DE) 2002-10-31 US disclosed
WO-2002079753-A2 2-AMINOBENZOXAZOLE DERIVATIVES AND COMBINATORIAL LIBRARIES THEREOF LION BIOSCIENCE AG (DE) 2002-10-10 WO disclosed
WO-2002051806-A1 CARBAZOLE DERIVATIVES AND THEIR USE AS NEUROPEPTIDE Y5 RECEPTOR LIGANDS ASTRAZENECA AB (SE) 2002-07-04 WO disclosed
EP-1176140-A1 AMIDE COMPOUNDS AND MEDICINAL USE THEREOF Mitsubishi Pharma Corporation (JP) 2002-01-30 EP disclosed
EP-0016277-A1 2-Carbonyl-3-hydroxy-alkenonitriles, their use as anti-arthritic agents and processes for their preparation AMERICAN CYANAMID COMPANY (US) 1980-10-01 EP disclosed